Skip to main content

Table 3 Population specific patient characteristics

From: Cost-effectiveness of ustekinumab in moderate to severe Crohn’s disease in Sweden

 

Conventional care failure [49]

TNF-alpha inhibitor failure [23]

Mean age (years)

39.2

37.3

Mean weight (kg)

73.4

69.8

Proportion female (%)

52.9

57.2

Patients < 55 kg (%)

19.4

22.9

Patients 56–84 kg (%)

59.7

58.8

Patients > 85 kg (%)

20.9

18.4

  1. TNF tumour necrosis factor, kg kilogram